AKA The clinic stack · Growth hormone pulse for sleep and body composition
CJC-1295 (no-DAC) plus Ipamorelin for sleep and body composition.
Last reviewed April 27, 2026 by Editorial team · 2 compounds
Information on this page is sourced from community use patterns and published research on each component. Educational only — not medical advice.
TL;DR
CYCLE
8-12 weeks on, 4 weeks off
| Compound | Role | Dose | Schedule | Route |
|---|---|---|---|---|
| CJC-1295 No-DAC variant, pre-bed only. | GHRH analog | 100 mcg no-DAC (pre-bed, stacked with ipamorelin 200-300 mcg) | Once daily (no-DAC) or weekly (DAC) | Subcutaneous |
| Ipamorelin Pre-bed, in the same syringe as CJC-1295. | GHS-R1a agonist | 200-300 mcg | 1-3x daily | Subcutaneous |
CJC-1295 stimulates GH release via the GHRH receptor, Ipamorelin stimulates it via the ghrelin receptor. The two pathways are complementary, which is why the combination is more potent than either alone. The pulse occurs naturally during deep sleep, pre-bed dosing aligns with that pulse.
GH stimulation is contraindicated for anyone with active or suspected cancer, severe diabetes, or pituitary disorders. Eat at least 90 minutes before dosing -- a meal blunts the GH pulse. Cycle off to avoid receptor desensitization.
Stacks are synthesized from community use patterns plus the published evidence on each component compound. See each compound's page for citations.